Department of Epidemiology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Japan.
Environ Health Prev Med. 2012 May;17(3):246-51. doi: 10.1007/s12199-011-0239-5. Epub 2011 Sep 10.
A growing number of epidemiological studies have demonstrated that the consumption of green tea inhibits the growth of a variety of cancers. Epigallocatechin gallate (EGCG), the most abundant catechin in green tea, has been shown to have an anti-cancer effect against many cancers. Most cancers are believed to be initiated from and maintained by a small population of tumor-initiating cells (TICs) that are responsible for chemotherapeutic resistance and tumor relapse. In neuroblastoma, an aggressive pediatric tumor that often relapses and has a poor prognosis, TICs were recently identified as spheres grown in a serum-free non-adherent culture used for neural crest stem cell growth. Although EGCG has been reported to induce growth arrest and apoptosis in neuroblastoma cells, its effect on neuroblastoma TICs remains to be defined.
Gene expression was analyzed by real-time reverse transcription polymerase chain reaction (RT-PCR). The effects of EGCG on cell proliferation, apoptosis, and sphere formation were determined by cell counting, propidium iodide staining, and sphere (>100 μm in diameter) counting, respectively.
Neuroblastoma BE(2)-C cells showed increased expression of stem cell markers (nanog homeobox [NANOG] and octamer-binding transcription factor 4 [OCT4]), as well as decreased expression of neuronal differentiation markers (Cu(2+)-transporting ATPase alpha polypeptide [ATP7A] and dickkopf homolog 2 [DKK2]) in spheres grown in serum-free non-adherent culture, compared to parental cells grown in conventional culture. Although EGCG induced growth arrest and apoptosis in the parental cells in a dose-dependent manner, it was not effective against spheres. However, EGCG potently inhibited sphere formation in the BE(2)-C cells.
The present results suggest that EGCG may inhibit the development of TICs in BE(2)-C cells.
越来越多的流行病学研究表明,绿茶的摄入能抑制多种癌症的生长。表没食子儿茶素没食子酸酯(EGCG)是绿茶中含量最丰富的儿茶素,已被证明对许多癌症具有抗癌作用。人们认为,大多数癌症是由一小部分肿瘤起始细胞(TICs)引发并维持的,这些细胞负责化疗耐药和肿瘤复发。神经母细胞瘤是一种侵袭性的儿科肿瘤,经常复发且预后不良,最近在无血清非贴壁培养中生长的球体中鉴定出了神经嵴干细胞生长的 TICs。虽然 EGCG 已被报道能诱导神经母细胞瘤细胞生长停滞和凋亡,但它对神经母细胞瘤 TICs 的影响仍有待确定。
通过实时逆转录聚合酶链反应(RT-PCR)分析基因表达。通过细胞计数、碘化丙啶染色和球(直径>100μm)计数分别测定 EGCG 对细胞增殖、凋亡和球体形成的影响。
与在常规培养中生长的亲本细胞相比,神经母细胞瘤 BE(2)-C 细胞在无血清非贴壁培养中生长的球体中表现出干细胞标记物(nanog 同源框[NANOG]和八聚体结合转录因子 4[OCT4])的表达增加,以及神经元分化标记物(Cu(2+)-转运 ATP 酶α多肽[ATP7A]和 dickkopf 同源物 2[DKK2])的表达减少。虽然 EGCG 以剂量依赖的方式诱导亲本细胞生长停滞和凋亡,但对球体无效。然而,EGCG 能强烈抑制 BE(2)-C 细胞的球体形成。
本研究结果表明,EGCG 可能抑制 BE(2)-C 细胞中 TIC 的发育。